Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Ozempic and Wegovy are now two of the biggest blockbuster ... to try to secure lower prices for specific high-cost drugs that don't have generic or biosimilar competition. CMS included 10 drugs ...

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer refused to cover Zepbound ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

They were originally prescribed to treat diabetes under the generic name semaglutide ... treatment of diabetes and Wegovy is FDA-approved for treating obesity. The drugs mimic a gut hormone ...

Retail drugs that have no generic equivalent and have been on the ... its blockbuster diabetes drug Ozempic and weight loss drug Wegovy. The company's top executive was called before the Senate ...

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...